GLP Watchdog

AquaVita NextGen vs Trimrose

Neither AquaVita NextGen nor Trimrose has an FDA warning letter on record. No price lines up like for like. They share compounded semaglutide injection, but AquaVita NextGen's $275 is a first-month price.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

AquaVita NextGen / Trimrose

AquaVita NextGen logo

AquaVita NextGen

6.6/10

Trimrose logo

Trimrose

6.4/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$275/moCompounded semaglutide injection, first month only
$269/moCompounded semaglutide injection
States
5 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit AquaVita NextGenFull review
Visit TrimroseFull review

Neither AquaVita NextGen nor Trimrose pays us. Links to them earn nothing. Scores: AquaVita NextGen 6.6, Trimrose 6.4. How we are paid

What the record shows

  1. 01

    Neither AquaVita NextGen nor Trimrose has an FDA warning letter on record.

  2. 02

    Trimrose names seven pharmacies. AquaVita NextGen names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but AquaVita NextGen's $275 is a first-month price.

  4. 04

    Only Trimrose lists a price for brand-name semaglutide pen and compounded oral semaglutide.

  5. 05

    Trimrose covers 45 states AquaVita NextGen does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

AquaVita NextGen

Trimrose

Compounded semaglutide injection

$275/mo

first month only; not compared

$269/mo

$3,228 a year

Compounded tirzepatide injection

$429/mo

first month only; not compared

$359/mo

$4,308 a year

Brand-name semaglutide pen
Not sold or not priced

$1,299/mo

$15,588 a year

Compounded oral semaglutide
Not sold or not priced

$299/mo

$3,588 a year

Price includes
Medication, clinician visits, shipping
Clinician visits, shipping
Minimum term
None stated
None stated (FAQ: no long-term commitments)
Refunds
All sales final; replacement or refund only for damaged or incorrect shipments
Not stated

Read off each seller’s own pages. AquaVita NextGen: October 17, 2026. Trimrose: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for AquaVita NextGen

6.6/10

The record gives AquaVita NextGen no edge on this pair.

  • Names no compounding pharmacy
  • Lowest price is a first-month price
Visit AquaVita NextGen

The case for Trimrose

6.4/10
  • Sells brand-name semaglutide pen and compounded oral semaglutide, which AquaVita NextGen does not price
  • Names its compounding pharmacy
  • Lists 50 states against 5
Visit Trimrose

Scores

AquaVita NextGen 6.6 · Trimrose 6.4 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
4.4

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

7.5A
vs
B
6.5

Accessibility10%

2.8A
vs
B
10.0

Support10%

7.0A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

AquaVita NextGen vs Trimrose: questions

Neither AquaVita NextGen nor Trimrose has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Trimrose names seven pharmacies. AquaVita NextGen names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but AquaVita NextGen's $275 is a first-month price. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Neither AquaVita NextGen nor Trimrose pays us. Links to them earn nothing. Scores: AquaVita NextGen 6.6, Trimrose 6.4.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks